Navigation Links
Results of new exploratory analyses assessing the incidence of hypoglycemia with linagliptin in adults with type 2 diabetes announced
Date:6/22/2013

sed in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis (increased ketones in the blood or urine). If patients have had pancreatitis in the past, it is not known if they have a higher chance of getting pancreatitis while taking linagliptin. Linagliptin is a DPP-4 inhibitor that does not require dose adjustment, regardless of declining renal function or hepatic impairment.

What are TRADJENTA tablets?
TRADJENTA is a prescription medicine that is used along with diet and exercise to lower blood sugar in adults with type 2 diabetes.

TRADJENTA is not for people with type 1 diabetes or for people with diabetic ketoacidosis (increased ketones in the blood or urine).

If you have had inflammation of the pancreas (pancreatitis) in the past, it is not known if you have a higher chance of getting pancreatitis while you take TRADJENTA.

Important Safety Information

What is the most important information I should know about TRADJENTA?
Serious side effects can happen to people taking TRADJENTA, including inflammation of the pancreas (pancreatitis), which may be severe and lead to death. Before you start taking TRADJENTA, tell your doctor if you have ever had pancreatitis, gallstones, a history of alcoholism, or high triglyceride levels.

Stop taking TRADJENTA and call your doctor right away if you have pain in your stomach area (abdomen) that is severe and will not go away. The pain may be felt going from your abdomen through to your back. The pain may happen with or without vomiting. These may be symptoms of pancreatitis.

Who should not take TRADJENTA?
Do not take TRADJENTA if you are allergic to linagliptin or any of the ingredients in TRADJENTA.

Symptoms of a serious allergic reaction to TRADJENTA may include rash, itching, flaking or peeling; raised red patches on your skin (hives); swelling of your face, lips, tongue and throat that may cause di
'/>"/>

SOURCE Eli Lilly and Company; Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013
2. China Cord Blood Corporation to Report Fourth Quarter and Full Year of Fiscal 2013 Financial Results
3. Ambit Announces Presentation of Results from Phase 2 ACE Study of Quizartinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) at the Annual Meeting of the American Society of Clinical Oncology
4. National Brain Tumor Society Responds to Results of Avastin Clinical Trials
5. AbbVie Presents Results from Phase I Study of Investigational Oncology Compound ABT-199 at American Society of Clinical Oncology Annual Meeting
6. GW Pharmaceuticals plc Reports 2013 Second Quarter Financial Results
7. CTI Reports Final Results from Cooperative Group and NCI-Sponsored Trial of Brostallicin in Patients with Metastatic Triple-Negative Breast Cancer
8. The Renewable Corporation (RNWB) through its wholly owned subsidiary EcoSmart Surface & Coating Technologies receives results from Product Test Service.
9. Pressure BioSciences, Inc. to Discuss First Quarter 2013 Financial Results and Provide Business Update
10. Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS)
11. Cempra Presents Post-Phase 2 Analysis of Solithromycins Efficacy and Safety Results from Patients with Community Acquired Bacterial Pneumonia (CABP)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... , Sept. 16, 2014 In preparation ... Texas -based cybersecurity company focused on authentication and ... will support the ability to generate a OTP through ... As a pioneer of user-based RFID authentication, 2FA,s solutions ... physical access, for many years. RFID authentication is broadly ...
(Date:9/15/2014)... , Sept. 15, 2014   Global Science ... of scientific products and services for satellite and ... Solution for Integrated Services (OASIS) from the General ... was selected to provide the government best-value solutions ... Business (SB) category in Pool 4. The OASIS ...
(Date:9/15/2014)... a patient has sepsis, a life-threatening condition in which ... often too fast for antibiotics to help. A new ... a team at Harvard,s Wyss Institute for Biologically Inspired ... , "Even with the best current treatments, sepsis ... 30 percent of the time," said Mike Super, Ph.D., ...
(Date:9/15/2014)... Sept. 15, 2014  iVinci Health LLC, the company ... Revenue Management system, branded as VisitPay®, has successfully closed ... the launch of a new extension to VisitPay® – ... easy and convenient way for patients to manage their ... by them and their families. The new ...
Breaking Biology Technology:2FA, Inc. Announces RFID-based One-Time Password (OTP) Authentication 2Global Science & Technology, Inc. Awarded GSA OASIS Small Business Contract 2Global Science & Technology, Inc. Awarded GSA OASIS Small Business Contract 3Blood-cleansing biospleen device developed for sepsis therapy 2Blood-cleansing biospleen device developed for sepsis therapy 3Blood-cleansing biospleen device developed for sepsis therapy 4iVinci Health Raises $5M to Fuel National Expansion, Announces Launch of Personal Finance Portal for Healthcare 2iVinci Health Raises $5M to Fuel National Expansion, Announces Launch of Personal Finance Portal for Healthcare 3
... , SANTA CLARA, Calif. , Jan. 28 Coherent, Inc. (Nasdaq: COHR ), a world leader in providing ... , FINANCIAL HIGHLIGHTS , , , , , ... Three Months Ended, ... ------------------, GAAP Results ...
... , MADRID , Jan. 28 The ... category goes to physicist and chemist Richard N. Zare , ... , of the University of Maryland , for their independent, ... unraveled secrets of nature,s building blocks and the underlying interactions between ...
... ... Webster Cavenee, Ph.D., and Frank Furnari, Ph.D., along with their team at ... Diego School of Medicine, have recently discovered one way that brain tumors ... stop tumor growth. This breakthrough discovery revealed a new cellular mechanism ...
Cached Biology Technology:Coherent, Inc. Reports Strong First Fiscal Quarter Results and Raises Annual Sales Guidance 2Coherent, Inc. Reports Strong First Fiscal Quarter Results and Raises Annual Sales Guidance 3Coherent, Inc. Reports Strong First Fiscal Quarter Results and Raises Annual Sales Guidance 4Coherent, Inc. Reports Strong First Fiscal Quarter Results and Raises Annual Sales Guidance 5Coherent, Inc. Reports Strong First Fiscal Quarter Results and Raises Annual Sales Guidance 6Coherent, Inc. Reports Strong First Fiscal Quarter Results and Raises Annual Sales Guidance 7Coherent, Inc. Reports Strong First Fiscal Quarter Results and Raises Annual Sales Guidance 8Coherent, Inc. Reports Strong First Fiscal Quarter Results and Raises Annual Sales Guidance 9Coherent, Inc. Reports Strong First Fiscal Quarter Results and Raises Annual Sales Guidance 10Coherent, Inc. Reports Strong First Fiscal Quarter Results and Raises Annual Sales Guidance 11Coherent, Inc. Reports Strong First Fiscal Quarter Results and Raises Annual Sales Guidance 12Zare and Fisher Win the BBVA Foundation Frontiers of Knowledge Award in Basic Sciences for Rendering Molecules Visible and Analyzing Their Collective Behavior 2Zare and Fisher Win the BBVA Foundation Frontiers of Knowledge Award in Basic Sciences for Rendering Molecules Visible and Analyzing Their Collective Behavior 3Zare and Fisher Win the BBVA Foundation Frontiers of Knowledge Award in Basic Sciences for Rendering Molecules Visible and Analyzing Their Collective Behavior 4Zare and Fisher Win the BBVA Foundation Frontiers of Knowledge Award in Basic Sciences for Rendering Molecules Visible and Analyzing Their Collective Behavior 5Zare and Fisher Win the BBVA Foundation Frontiers of Knowledge Award in Basic Sciences for Rendering Molecules Visible and Analyzing Their Collective Behavior 6Zare and Fisher Win the BBVA Foundation Frontiers of Knowledge Award in Basic Sciences for Rendering Molecules Visible and Analyzing Their Collective Behavior 7NFCR Scientists Discover Brain Tumor's “Escape Path” 2NFCR Scientists Discover Brain Tumor's “Escape Path” 3
(Date:9/15/2014)... allow us to better understand how the fish ... and provide the type of environmental data to ... siting of protected areas," said Paula Whitfield, a ... Ocean Science (NCCOS) and lead author of the ... the temperate-tropical transition zone, where historically, both temperate ...
(Date:9/15/2014)... 500 million years after it formed may have been ... continents and active crustal plates. , This alternate view ... gained substantial new support from the first detailed comparison ... years ago with those formed contemporaneously in Iceland, which ... early Earth. , The study was conducted by a ...
(Date:9/15/2014)... hearing and cognitive function may play roles in one,s ... rhythm, pitch, timbre, tone durations, and formal structure in ... article explain that extremes in musical aptitude (extreme capacity/no ... of individuals having moderate aptitude. , "This is a ... underlying genes, and it is influenced to varying degrees ...
Breaking Biology News(10 mins):Study finds warming Atlantic temperatures could increase range of invasive species 2Early Earth less hellish than previously thought 2Early Earth less hellish than previously thought 3
... ovarian ,chocolate, cysts for the brown liquid they contain, ... common, which can cause ongoing pain and complications. A ... and effective remedy the oral contraceptive pill (OCP). ... Reilly from Auckland, New Zealand, highlight a trial published ...
... AUGUSTA, Ga. - New drugs that are helping fight ... cardiovascular disease, Medical College of Georgia researchers said. Cancer ... as a cause. Heat shock protein 90 inhibitors as a ... director of MCG,s Vascular Biology Center. "I think hsp90 ...
... use of Chinese wolfberries to improve vision deficiencies that are ... assistant professor of human nutrition, is studying wolfberries and their ... that the fruit can lower the oxidative stress that the ... would not say that wolfberries are a medicine, but they ...
Cached Biology News:New cancer therapy may fight cardiovascular disease 2Study uses Chinese wolfberries to improve vision imperfections caused by type-2 diabetes 2Study uses Chinese wolfberries to improve vision imperfections caused by type-2 diabetes 3
... custom siRNA service provides the premium quality ... research. Custom siRNAs can be readily ordered ... target sequence, or by providing the sense ... Ambion's Silencer Validated and Silencer Pre-designed siRNAs, ...
... Ambion's custom siRNA service provides the premium ... silencing research. Custom siRNAs can be readily ... base target sequence, or by providing the ... out Ambion's Silencer Validated and ...
Human SDNSF/MCFD2 Biotinylated Affinity Purified PAb...
Recombinant Ovine (Sheep) Prolactin, Ultra Pure...
Biology Products: